Pharmacyclics, J&J drug shown to improve leukemia survivalReutersCHICAGO (Reuters) – A new drug for the most common form of leukemia in adults improves survival for patients whose disease has worsened despite standard treatment, according to late-stage study findings released on Saturday. Ibrutinib, sold by …New Pill Helps Leukemia Patients Live LongerNBCNews.comPharmacyclics’ Leukemia Drug Beats Glaxo’s in Head-to-Head TrialBloombergPharmacyclics’ Imbruvica Extends Survival in Elderly Leukemia PatientsTheStreet.comMarketWatch -PR Newswire UK (press release)all 7 news articles …Read Full Story
Pharmacyclics, J&J drug shown to improve leukemia survival - Reuters
Real Estate of Cebu
